Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Full-dose RAS blockade versus prednisone for IgA nephropathy
ChiCTR-TRC-09000338Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- May 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prednisone in IgA nephropathy (IgAN) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Serum creatinine concentration. Started May 2009; status: completed.
02
Drugs
prednisone
03
Conditions
IgA nephropathy (IgAN)
Beyond the preview
Go deeper on ChiCTR-TRC-09000338.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000338.